Canada: A new study from Canada has shed light on the role of multiple oralhuman papillomavirus (HPV)infections in the development ofhead and neck cancer (HNC), emphasizing the potential impact of HPVvaccinationin reducing disease risk. Conducted by Belinda F. Nicolau and colleagues from McGill University, Montreal, the research highlights that co-infection with multiple alpha-HPV types significantly increases the likelihood of developing HNC.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!